Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
What To Look For In A Cash Back Credit Card
Explore essential factors to consider when choosing a cash back credit card. Understand features that maximize your rewards effectively.
23,701 articles
Accenture Stock Gets Price Target Cuts Amid AI Debate
Accenture beat on earnings and bookings, but two major firms trimmed price targets as investors weigh AI’s effect on ...
Where Will Costco Stock Be in 2029: Outlook and Risks
Costco faces a pivotal question for 2029: can it sustain double-digit earnings growth and margin resilience to lift C...
BlackRock’s Bitcoin Premium Income ETF Lands on Nasdaq
BlackRock launches BITA, a Bitcoin Premium Income ETF that channels crypto volatility into monthly distributions via ...
Stellar Times More Tokenized Assets Than XRP, Yet XRP Is 11x
Stellar leads in on-chain real-world asset tokenization, but XRP still dominates in price. The divergence spotlights ...
HDV's 2.86% Yield, 0.08% Fee: The Anti-Hype ETF Strategy
As AI hype cools, dividend-focused ETFs draw buyers seeking steadiness. HDV delivers a modest yield with a low fee an...
Why July Brings Two SSI Payments for Some Recipients
In July 2026, certain Social Security recipients will see two SSI payments in one month due to the calendar. The Augu...
TSLA Down 2026: Reddit Losses Faith at Rapid Pace Today
Tesla’s shares fall in 2026 as Reddit users grow increasingly bearish, prompting a broader rethink of the EV leader’s...
Ford Winnebago: American Vehicle Makers Navigate Tough Road
Ford faced a massive quarterly loss tied to EV charges, while Winnebago posted a surprise profit swing on premium mot...
NVIDIA Price Target Raised as Blackwell Revenue Looms
Analysts push a higher target for NVIDIA as demand for Blackwell and Vera Rubin accelerates. The latest guidance sign...
Super Micro Doubled Revenue, Yet Stock Remains Flat
Super Micro Computer reports revenue that more than doubles year over year, yet the shares sit flat as questions abou...
UBS Upgrades Jazz Pharmaceuticals to Buy, Sets $307 Target
UBS has lifted Jazz Pharmaceuticals to Buy with a $307 price target, arguing that improving fundamentals and a stren...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status